These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11953352)

  • 1. Use of antisecretory agents as a trial of therapy.
    Fennerty MB
    Gut; 2002 May; 50 Suppl 4(Suppl 4):iv63-6. PubMed ID: 11953352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-week omeprazole treatment in the diagnosis of gastro-oesophageal reflux disease.
    Johnsson F; Weywadt L; Solhaug JH; Hernqvist H; Bengtsson L
    Scand J Gastroenterol; 1998 Jan; 33(1):15-20. PubMed ID: 9489902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying response to acid suppressive therapy in functional dyspepsia using a random starting day trial--is gastro-oesophageal reflux important?
    Madsen LG; Wallin L; Bytzer P
    Aliment Pharmacol Ther; 2004 Aug; 20(4):423-30. PubMed ID: 15298636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients with functional dyspepsia responding to omeprazole have a characteristic gastro-oesophageal reflux pattern.
    Farup PG; Hovde O; Torp R; Wetterhus S
    Scand J Gastroenterol; 1999 Jun; 34(6):575-9. PubMed ID: 10440606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of omeprazole as a cost-effective diagnostic test for gastro-oesophageal reflux disease.
    Bate CM; Riley SA; Chapman RW; Durnin AT; Taylor MD
    Aliment Pharmacol Ther; 1999 Jan; 13(1):59-66. PubMed ID: 9892880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term course of reflux symptoms following Helicobacter pylori eradication].
    Peitz U; Raps S; Plein K; Leodolter A; Hotz Dagger J; Malfertheiner P
    Dtsch Med Wochenschr; 2004 Mar; 129(13):671-5. PubMed ID: 15026962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying responders to acid suppression in dyspepsia using a random starting day trial.
    Bytzer P; Hansen JM; Rune S; Bonnevie O; Breinstrup H; Funch-Jensen P; Matzen P; Meineche-Schmidt V; Schaffalitzky De Muckadell OB
    Aliment Pharmacol Ther; 2000 Nov; 14(11):1485-94. PubMed ID: 11069320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acid suppression does not change respiratory symptoms in children with asthma and gastro-oesophageal reflux disease.
    Størdal K; Johannesdottir GB; Bentsen BS; Knudsen PK; Carlsen KC; Closs O; Handeland M; Holm HK; Sandvik L
    Arch Dis Child; 2005 Sep; 90(9):956-60. PubMed ID: 16113133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving health-related quality of life in gastro-oesophageal reflux disease.
    Shaw MJ; Crawley JA
    Drugs; 2003; 63(21):2307-16. PubMed ID: 14524732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omeprazole for asthma with gastro-oesophageal reflux.
    Field SK
    Eur Respir J; 1999 Jun; 13(6):1495. PubMed ID: 10445632
    [No Abstract]   [Full Text] [Related]  

  • 11. Epigastric pain in dyspepsia and reflux disease.
    Vakil N
    Rev Gastroenterol Disord; 2003; 3 Suppl 4():S16-21. PubMed ID: 14671510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lansoprazole: an update of its place in the management of acid-related disorders.
    Matheson AJ; Jarvis B
    Drugs; 2001; 61(12):1801-33. PubMed ID: 11693467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of potent acid inhibition in gastro-oesophageal reflux disease.
    Monés J
    Drugs; 2005; 65 Suppl 1():35-42. PubMed ID: 16335856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omeprazole. A review of its use in Helicobacter pylori infection, gastro-oesophageal reflux disease and peptic ulcers induced by nonsteroidal anti-inflammatory drugs.
    Langtry HD; Wilde MI
    Drugs; 1998 Sep; 56(3):447-86. PubMed ID: 9777317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastroesophageal reflux disease symptoms on antisecretory therapy: acid, non-acid, or no GERD.
    Katz PO
    Rev Gastroenterol Disord; 2006; 6(3):136-45. PubMed ID: 16957654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Famotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non-erosive gastro-oesophageal reflux disease.
    Fujiwara Y; Higuchi K; Nebiki H; Chono S; Uno H; Kitada K; Satoh H; Nakagawa K; Kobayashi K; Tominaga K; Watanabe T; Oshitani N; Arakawa T
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():10-8. PubMed ID: 15943841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cost of long term therapy for gastro-oesophageal reflux disease: a randomised trial comparing omeprazole and open antireflux surgery.
    Myrvold HE; Lundell L; Miettinen P; Pedersen SA; Liedman B; Hatlebakk J; Julkunen R; Levander K; Lamm M; Mattson C; Carlsson J; Ståhlhammar NO;
    Gut; 2001 Oct; 49(4):488-94. PubMed ID: 11559644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of a therapeutic trial of high-dose rabeprazole on symptom response of patients with non-cardiac chest pain: a randomized, double-blind, placebo-controlled, crossover trial.
    Dickman R; Emmons S; Cui H; Sewell J; Hernández D; Esquivel RF; Fass R
    Aliment Pharmacol Ther; 2005 Sep; 22(6):547-55. PubMed ID: 16167971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of an empirical trial of high-dose lansoprazole on symptom response of patients with non-cardiac chest pain--a randomized, double-blind, placebo-controlled, crossover trial.
    Bautista J; Fullerton H; Briseno M; Cui H; Fass R
    Aliment Pharmacol Ther; 2004 May; 19(10):1123-30. PubMed ID: 15142202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managing gastro-oesophageal reflux disease in children.
    Cezard JP
    Digestion; 2004; 69 Suppl 1():3-8. PubMed ID: 15001829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.